NCT00417690 - High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

October 31, 2008

Conditions

Crohn's Disease

Interventions

DRUG

4-Aminosalicylic acid

Oral granules administered as one 4 g packet three times daily for two weeks followed by one 4 g packet two times daily for two weeks

DRUG

PASER placebo granules

Oral granules administered administered as one packet three times daily for two weeks followed by one packet two times daily for two weeks

Trial Locations (5)

Mount Sinai School of Medicine IBD Research Center, New York

Charlotte Gastroenterology and Hepatology, PLLC, Charlotte

Rambam Medical Center, Haifa

The University of Chicago, Chicago

Tel-Aviv Sourasky Medical Center, Tel Aviv